Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$11.33 - $19.81 $22,660 - $39,620
-2,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.74 - $7.42 $11,480 - $14,840
2,000 New
2,000 $15,000
Q2 2019

Aug 14, 2019

SELL
$4.67 - $5.88 $9,340 - $11,760
-2,000 Closed
0 $0
Q1 2019

May 16, 2019

BUY
$4.19 - $5.25 $8,380 - $10,500
2,000 New
2,000 $11,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.